Strategy-Proofness, Investment Efficiency, and Marginal Returns: An Equivalence

John William Hatfield; Fuhito  Kojima; Scott Duke Kominers

Working Paper | 2015

Strategy-Proofness, Investment Efficiency, and Marginal Returns: An Equivalence

by John William Hatfield, Fuhito Kojima and Scott Duke Kominers

Abstract

We show that a mechanism induces an agent to make efficient ex ante investment choices if and only if it rewards that agent with his marginal surplus; additionally, for an ex post efficient mechanism, these properties are equivalent to strategy-proofness for the agent. Our results extend to settings with uncertainty; moreover, they have analogs for mechanisms that are only approximately efficient and approximately incentive compatible. Among other applications, our results imply both that under the worker-optimal stable mechanism, workers are incentivized to make efficient human capital investments before entering the labor market, and that second-price auctions induce efficient bidder participation.

Keywords: Strategy-proofness; Investment efficiency; Providing marginal rewards; Vickrey-Clarke-Groves mechanisms; Mechanism design; Market Design; Human Capital;

Language: English

Format: Print

SSRN

Citation:

Hatfield, John William, Fuhito Kojima, and Scott Duke Kominers. "Strategy-Proofness, Investment Efficiency, and Marginal Returns: An Equivalence." Working Paper, January 2015.

COVID-19 convalescent plasma (CCP) therapy is currently a leading treatment for COVID-19. At present, there is a shortage of CCP relative to demand. We develop and analyze a model of centralized CCP allocation that incorporates both donation and distribution. In order to increase CCP supply, we introduce a mechanism that utilizes two incentive schemes, respectively based on principles of “paying it backward" and “paying it forward." Under the first scheme, CCP donors obtain treatment vouchers that can be transferred to patients of their choosing. Under the latter scheme, patients obtain priority for CCP therapy in exchange for a future pledge to donate CCP if possible. We show that in steady-state, both principles generally increase overall treatment rates for all patients—not just those who are voucher-prioritized or pledged to donate. Our results also hold under certain conditions if a fraction of CCP is reserved for patients who participate in clinical trials. Finally, we examine the implications of pooling blood types on the efficiency and equity of CCP distribution.

We prove configuration results for extremal Type II codes, analogous to the configuration results of Ozeki and of the second author for extremal Type II lattices. Specifically, we show that for n ∈{8,24,32,48,56,72,96} every extremal Type II code of length n is generated by its codewords of minimal weight. Where Ozeki and Kominers used spherical harmonics and weighted theta functions, we use discrete harmonic polynomials and harmonic weight enumerators. Along the way we introduce "t12-designs" as a discrete analog of Venkov's spherical designs of the same name.

Faculty & Research

Strategy-Proofness, Investment Efficiency, and Marginal Returns: An Equivalence

Abstract

Citation:

About the Author

More from the Author